Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: An in vitro model to assess drug neurotoxicity

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2477-2481

  Nicolini, Gabriella ^a   Miloso, Mariarosaria ^a   Zoia, Chiara ^a,b   Di Silvestro, Andrea ^a   Cavaletti, Guido ^a,b   Tredici, Giovanni ^a,c  

^a Dipartimento di Chimica e Biochimica   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Istituto di Anatomia Umana   (Italy)

Author keywords

Chemotherapy neurotoxicity; Cisplatin neurotoxicity; Human neuroblastoma; Neuronal differentiation; SH SY5Y

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; RETINOIC ACID;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL PRACTICE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; HUMAN; HUMAN CELL; NEURITE; NEUROBLASTOMA; NEUROTOXICITY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CISPLATIN; CYCLOPHOSPHAMIDE; HUMANS; KINETICS; NEURITES; NEUROBLASTOMA; NEURONS; NEUROTOXINS; TIME FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031864792     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Konings PN, Makkink WK, van Deft AML and Ruigt GSF: Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro. Brain Res 640: 195-204, 1994.
2. Windebank AJ and Blexrud MD: Characteristics of neurite outgrowth from rat spinal ganglia: effects of serum and segmental level. J Neuropathol Exp Neurol 45: 683-691, 1986.
3. Windebank AJ, Smith AG and Russell JW: The effect of nerve growth factor, ciliary neurotrophic factor and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology 44: 488-494, 1994.
4. Geldof AA: Nerve-growth-factor-dependent neurite outgrowth assay; a research model for chemotherapy-induced neuropathy. J Cancer Res Clin Oncol 121: 657-660, 1995.
5. Cavaletti G, Cascinu S, Venturino P, Tedeschi M and Tredici G: Neuroprotectant drugs in cisplatin neurotoxicity. Anticancer Res 16: 3149-3159, 1996.
6. Biedler JL, Helson L and Spengler BA: Morphology and growth, tumorigenicity, and cytokinetics of human neuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652, 1973.
7. Hynds DL, Summers M, Van Brocklyn JR, O'Dorisio MS and Yates AJ: Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation and dimerization in neuroblastoma SH-SY5Y. J Neurochem 65: 2251-2258, 1995.
8. Hynds DL, Burry RW and Yates AJ: Gangliosides inhibit growth factor-stimulated neurite outgrowth in SH-SY5Y human neuroblastoma cells. J Neurosci Res 47: 617-625, 1997.
9. Grynspan F, Griffin WB, Mohan PS and Shea TB: Calpains and calpastatin in SH-SY5Y neuroblastoma cells during retinoic acid-induced differentiation and neurite outgrowth: comparison with the human brain calpain system. J Neurosci Res 48: 181-191, 1997.
10. Ciccarone V, Spengler BA, Meyers MB, Biedler JL and Ross RA: Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49: 219-225, 1989.
11. Ross RA, Spengler BA and Biedler JL: Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Nat Cancer Inst 71: 741-747, 1983.
12. Cece R, Barajon I and Tredici G: Cisplatin induces apoptosis in SH-SY5Y human neuroblastoma cell line. Anticancer Res 15: 777-782, 1995.
13. Malgrange B, Delée P, Rigo JM, Baron H and Moonen G: Image analysis of neuritic regeneration by adult rat dorsal root ganglion neurons in culture: quantification of neurotoxicity of anticancer agents and of its prevention by nerve growth factor or basic fibroblast growth factor but not brain-derived neurotrophic factor or neurotrophin-3. J Neurosci Meth 53: 111-122, 1994.
14. Mollman JE: Cisplatin neurotoxicity. N Eng J Med 322: 126-127, 1990.
15. Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I and Fabbrica D: Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol 84: 364-371, 1992.
16. Cavaletti G, Tredici G, Marmiroli P, Fabbrica D and Braga M: Off-treatment course of cisplatin-induced dorsal root ganglia neuronopathy in rats. In vivo 8: 313-316, 1994.
17. Tredici G, Tredici S, Fabbrica D, Minoia C and Cavaletti G: Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J Neuroncol 36: 31-40, 1998.
18. Gold BG, Zeleny-Pooley M, Wang MS, Chaturvedi P and Armistead DM: A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp Neurol 147: 269-278, 1997.